Arsenic Trioxide 10mg/10mL (1mg/mL) Injection

Arsenic Trioxide 10mg/10mL (1mg/mL) is a differentiating anticancer medicine for acute promyelocytic leukaemia, used alone or with all-trans retinoic acid according to the risk and treatment setting.
The concentrate is diluted and given by intravenous infusion in a monitored oncology setting. ECG, electrolytes and clinical observations guide treatment. It is not an intravenous bolus.
Arsenic trioxide promotes degradation of the PML–RARα fusion protein and encourages differentiation and death of abnormal promyelocytes.
Nausea, fatigue, oedema, increased glucose and liver-enzyme changes may occur. Differentiation syndrome and QT prolongation are potentially life-threatening.
Potassium and magnesium are corrected and monitored. Fever, weight gain, swelling or breathlessness may indicate differentiation syndrome and requires urgent treatment. QT-prolonging medicines increase arrhythmia risk.
Promoting maturation and removal of abnormal promyelocytes can produce remission in a molecularly defined leukaemia.
No. Its established role is specific to APL, generally involving the PML–RARα abnormality.
It is an inflammatory complication that can cause fever, fluid retention, low blood pressure and breathing difficulty. It needs immediate treatment.
QT prolongation can lead to dangerous rhythm disturbances, particularly with low potassium or magnesium.
Peripheral nerve effects can occur. Report new or worsening numbness, tingling or limb weakness promptly, particularly if it affects walking, balance or using your hands.
APL: acute promyelocytic leukaemia. Differentiation: maturation of cells. QT prolongation: delayed cardiac electrical recovery.; AR: Arsenic Trioxide 10mg/10mL (1mg/mL) حقن; FR: Arsenic Trioxide 10mg/10mL (1mg/mL) injection; PT: Arsenic Trioxide 10mg/10mL (1mg/mL) injeção; ES: Arsenic Trioxide 10mg/10mL (1mg/mL) inyección; RU: Arsenic Trioxide 10mg/10mL (1mg/mL) инъекция; ID: Arsenic Trioxide 10mg/10mL (1mg/mL) suntikan; VI: Arsenic Trioxide 10mg/10mL (1mg/mL) thuốc tiêm; MS: Arsenic Trioxide 10mg/10mL (1mg/mL) suntikan; TL: Arsenic Trioxide 10mg/10mL (1mg/mL) iniksyon; ZH-SG: Arsenic Trioxide 10mg/10mL (1mg/mL) 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Arsenic Trioxide 10mg/10mL (1mg/mL) Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Arsenic Trioxide 10mg/10mL (1mg/mL) Injection